News Focus
News Focus
icon url

biopharm

03/01/17 1:26 PM

#288032 RE: cjgaddy #288030

Nice find CJ! ...this is starting out to be one hell of a March 2017 for Peregrine

I could not imagine sitting across the negotiating table when the leverage is completely on Peregrines side!

...things can happen fast now...
icon url

BioBS2012

03/01/17 1:45 PM

#288033 RE: cjgaddy #288030

Cedars-Sinai Researcher lists PPHM in her Disclosures in this Joint Mem.Sloan/Cedars-Sinai AACR’17 Abstract, where she's the Lead Author, along with co-authors Jedd Wolchok, Taha Merghoub, and several other Mem. Sloan researchers. So, 2 of Dr. Wolchok’s 5 AACR’17 abstracts are Joint PPHM+MemSloan, and a 3rd is Joint CedarsSinai+MemSloan whereby the Lead Author lists Peregrine in her disclosures. Maybe we need to add Cedars-Sinai to our collabs list along with Memorial Sloan Kettering, Duke, MDA, Rutgers, ImmunoVaccine, and UTSW.

Digging a little further, found this article which has both authors advising Peregrine (see bottom of article). From the topic of their work, it would appear they are advisers to Peregrine for the breast-cancer trial design - JMO

Dr. McArthur & Dr. Page
icon url

asmarterwookie

03/01/17 1:49 PM

#288034 RE: cjgaddy #288030

Thank you sir. I think volume will go bonkers soon.

Wookie needs a new home...LOL

wook